Education
About Us
Working with TipRanks
Follow Us
China Resources Medical Holdings Co (HK:1515)
:1515
1515 Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume1.57M
Average Volume (3M)N/A
Market Cap
$5.00B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
China Resources Medical Holdings Co News
PremiumCompany Announcements
China Resources Medical Holdings Co Reports Increased Profitability in 2024
PremiumCompany Announcements
China Resources Medical Holdings Announces Final Dividend for 2024
PremiumCompany Announcements
China Resources Medical Holdings Announces Upcoming Board MeetingPremiumCompany Announcements
China Resources Medical Holdings Co Wins Legal Dispute with Yanhua Parties
PremiumCompany Announcements
China Resources Medical Holdings Reports 119% Profit Surge for 2024
PremiumCompany Announcements
China Resources Medical Announces New Travel Service Agreement
PremiumCompany Announcements
China Resources Medical Secures IT Services DealPremiumCompany Announcements
China Resources Medical Reports Profit Growth---
Bulls Say, Bears Say
Bulls Say
Asset InjectionsFurther asset injections from parent company another driver, historically a major share price catalyst for CR Medical.
DividendsInterim dividend of RMB0.05/sh declared – first time since China Resource Group took over.
EarningsEarnings growth driven by a 35% finance cost drop, 16% income tax drop, and 99.8% foreign exchange net loss drop.
Bears Say
ASP DeclinesModest patient volume growth was overshadowed by ASP declines on continual reimbursement pressure.
Integration CostsAdditional cost of integrating assets from parent company.
Reimbursement PressureManagement expects a similar degree of reimbursement pressure for 2025 as compared to 2H24.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.18%
Mutual Funds
― Other Institutional Investors
94.77% Public Companies and
Individual Investors
1515 FAQ
What was China Resources Medical Holdings Co ’s price range in the past 12 months?
Currently, no data Available
What is China Resources Medical Holdings Co ’s market cap?
China Resources Medical Holdings Co ’s market cap is $5.00B.
When is China Resources Medical Holdings Co ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were China Resources Medical Holdings Co ’s earnings last quarter?
Currently, no data Available
Is China Resources Medical Holdings Co overvalued?
According to Wall Street analysts China Resources Medical Holdings Co ’s price is currently Overvalued.
Does China Resources Medical Holdings Co pay dividends?
China Resources Medical Holdings Co does not currently pay dividends.
What is China Resources Medical Holdings Co ’s EPS estimate?
China Resources Medical Holdings Co ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Resources Medical Holdings Co have?
Currently, no data Available
What happened to China Resources Medical Holdings Co ’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of China Resources Medical Holdings Co ?
Currently, no hedge funds are holding shares in HK:1515
---